Details of the Drug Reposition

General Information of This Drug (ID: DMQ2FKJ)

Drug Name
Teriflunomide   DMQ2FKJ
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lupus nephritis DISCVGPZ 4A40.0Y Approved [1]
Hyperlipidaemia DIS4R2OG 5C80 Approved [2]
Multiple sclerosis DISB2WZI 8A40 Approved [3]
Psoriatic arthritis DISLWTG2 FA21 Approved [1]
------------------------------------------------------------------------------------
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rheumatoid arthritis DISTSB4J FA20 Phase 3 [3]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hepatitis B virus infection DISLQ2XY 1E51.0 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Teriflunomide FDA Label
2 Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6844).